Interestingly, although competing ATG-101 and anti-PD-L1 reduced tumour uptake of [89Zr]Zr-Df-ATG-101 on day 2, the blocking effect was not evident on day 7 (Fig. 5b). This evidence concerns the gene CD274 and neoplasm.